DAX19.323 +0,9%ESt504.789 +0,7%MSCIW3.766 +0,3%Dow44.297 +1,0%Nas19.004 +0,2%Bitcoin93.728 -0,1%Euro1,0417 -0,6%Öl75,28 +1,2%Gold2.709 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 MicroStrategy 722713 Tesla A1CX3T Rheinmetall 703000 Siemens Energy ENER6Y Volkswagen (VW) vz. 766403 Bayer BAY001 Deutsche Telekom 555750 Amazon 906866 Mercedes-Benz Group (ex Daimler) 710000 BASF BASF11 Palantir A2QA4J Allianz 840400 Apple 865985 BioNTech (ADRs) A2PSR2
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX geht deutlich fester ins Wochenende -- US-Börsen schließen höher -- Bitcoin knapp vor 100.000 US-Dollar -- Chef der US-Börsenaufsicht tritt ab -- RWE, Secunet, NEL im Fokus
Top News
Top-Angebote schon vor dem Black Friday - Black Friday Week bei Amazon und Co. starten schon jetzt Top-Angebote schon vor dem Black Friday - Black Friday Week bei Amazon und Co. starten schon jetzt
KW 47: Bitcoin, Ether & Co. - Wochenperformance der Kryptowährungen KW 47: Bitcoin, Ether & Co. - Wochenperformance der Kryptowährungen
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

CTI BioPharma Aktie

NeuKaufenVerkaufen
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Bei einem anderen Broker handelnSmartphone
Div. Rendite0,00%

WKNA2DJWX

ISINUS12648L6011

SymbolCTIC

CTI BioPharma Aktien News

DatumMeistgelesen
PR NewswireSobi successfully completes tender offer for all outstanding shares of common stock of CTI BioPharma Corp.
PR NewswireSobi successfully completes tender offer for all outstanding shares of common stock of CTI BioPharma Corp.
PR NewswireCTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders
PR NewswireMoore Kuehn Encourages HMPT, ABST, CTIC and FRG Investors to Contact Law Firm
PR NewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTIC, LTHM, SYNH, FRG
PR NewswireShareholder Alert: Ademi LLP investigates whether CTI BioPharma Corp. has obtained a Fair Price in its transaction with Sobi
PR NewswireSobi to Acquire CTI BioPharma
PR NewswireCTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireCTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireCTI BioPharma To Report First Quarter 2023 Financial Results and Provide Corporate Update on Thursday, May 11, 2023
PR NewswireCTI BioPharma Announces Two Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
PR NewswireCTI BioPharma to Participate in Two Upcoming Investor Conferences in April 2023
PR NewswireCTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireCTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireCTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireCTI BioPharma Reports Fourth Quarter and Full Year 2022 Financial Results
PR NewswireCTI BioPharma to Present at the 43rd Annual Cowen Health Care Conference
PR NewswireCTI BioPharma To Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on Monday, March 6, 2023
PR NewswireCTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireCTI BioPharma to Participate in Upcoming Investor Conferences in February 2023
PR NewswireCTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireCTI BioPharma to Present at the 41st Annual J.P. Morgan Healthcare Conference
PR NewswireCTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireCTI BioPharma Presents New Anemia Benefit Data from Pacritinib Program at the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition
PR NewswireCTI BioPharma to Present at the JMP Securities Hematology and Oncology Summit
PR NewswireCTI BioPharma to Present at Upcoming November Conferences
PR NewswireCTI BioPharma Reports Third Quarter 2022 Financial Results
PR NewswireCTI BioPharma Announces Oral Presentation at the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition
PR NewswireCTI BioPharma to Report Third Quarter 2022 Financial Results on November 7, 2022
PR NewswireCTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireCTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireCTI BioPharma Announces Presentation of New Anemia Benefit Data from Pacritinib Program at the Society of Hematologic Oncology (SOHO) Tenth Annual Meeting
PR NewswireCTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireCTI BioPharma Reports Second Quarter 2022 Financial Results
PR NewswireCTI BioPharma to Report Second Quarter 2022 Financial Results on August 8, 2022
PR NewswireCTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireCTI BioPharma Presents Pivotal Data from Pacritinib Program at the European Hematology Association (EHA) 2022 Congress
PR NewswireCTI BioPharma to Present at Upcoming June Conferences
PR NewswireCTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireCTI BioPharma Presents Pivotal Data from Pacritinib Program at the 2022 American Society of Clinical Oncology Annual Meeting

CTI BioPharma News

CTI BioPharma News: auf dieser Seite finden Sie alle CTI BioPharma News und Nachrichten zur CTI BioPharma Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch CTI BioPharma News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um CTI BioPharma News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.